Cross Country Healthcare (NASDAQ:CCRN - Get Free Report)'s stock had its "market perform" rating reaffirmed by investment analysts at Barrington Research in a research report issued to clients and investors on Friday,Benzinga reports. They presently have a $18.61 target price on the business services provider's stock. Barrington Research's price target points to a potential upside of 24.44% from the company's current price.
CCRN has been the topic of a number of other reports. StockNews.com began coverage on shares of Cross Country Healthcare in a research note on Wednesday, March 12th. They issued a "hold" rating on the stock. Truist Financial lifted their price objective on shares of Cross Country Healthcare from $15.00 to $18.61 and gave the company a "hold" rating in a research note on Thursday, December 5th. JMP Securities restated a "market perform" rating on shares of Cross Country Healthcare in a research note on Thursday, February 6th. William Blair lowered shares of Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, December 4th. Finally, Benchmark lowered shares of Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, December 4th. Six equities research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $18.41.
Get Our Latest Report on Cross Country Healthcare
Cross Country Healthcare Stock Down 2.4 %
CCRN traded down $0.37 on Friday, reaching $14.96. The company had a trading volume of 308,236 shares, compared to its average volume of 582,364. The stock has a market capitalization of $490.72 million, a PE ratio of -299.04, a P/E/G ratio of 3.32 and a beta of 0.44. Cross Country Healthcare has a 1 year low of $9.58 and a 1 year high of $19.25. The stock has a 50-day moving average price of $17.62 and a 200-day moving average price of $15.18.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Quadrant Capital Group LLC acquired a new position in Cross Country Healthcare during the fourth quarter worth about $25,000. Plato Investment Management Ltd purchased a new stake in shares of Cross Country Healthcare in the fourth quarter valued at about $46,000. Truvestments Capital LLC purchased a new stake in shares of Cross Country Healthcare in the third quarter valued at about $39,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Cross Country Healthcare in the third quarter valued at about $49,000. Finally, Point72 DIFC Ltd purchased a new stake in shares of Cross Country Healthcare in the third quarter valued at about $52,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Cross Country Healthcare Company Profile
(
Get Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
See Also

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.